Skip to content

Exagen Inc. XGN Reportable Segment — Loss from operations

Similar metrics at other companies

AIR
AIRSReportable Segment — Loss from operations
-$1.8M-13.4%
Lexicon Pharmaceuticals logo
LXRXReportable Segment — Loss from operations
-$996K+96.1%
Archer Aviation logo
ACHRReportable Segment — Loss from operations
-$254.6M-76.8%
Shattuck Labs, Inc. logo
STTKReportable Segment — Loss from operations
-$15.55M-8.0%
Stitch Fix logo
SFIXReportable Segment — Net loss from continuing operations
-$1.53M+79.3%
Aquestive Therapeutics, Inc. logo
AQSTReportable Segment — Operating Income (Loss)
-$4.2M+78.3%

Other financials

Income statement

See full
Revenue$17.3M+11.7%
Gross profit$10.2M+11.9%
Operating income-$3.4M-1.5%
Net income-$4.0M-5.7%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$21.7M+90.6%
Total debt$27.1M+15.8%
Total equity$14.4M+125%
Total assets$52.0M+28.9%

Cash flow

See full
Operating cash flow-$10.4M+2.4%
CapEx$228.0K+102%
Free cash flow-$10.6M+1.3%

Valuation

See full
Market cap$112.34M-26.5%
Enterprise value$117.78M-20.3%
P/S1.6×-1.0×

Profitability

See full
Gross margin58.3%-1.0pp
Operating margin-20.6%-2.9pp
Net margin-29.5%+2.5pp
FCF margin-27.5%

Returns & leverage

See full
Return on equity-193.6%+355pp
Debt / equity1.9×-1.8×
Current ratio3.5×+1.1×

Where this comes from

Reported directly by Exagen Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s reportable segment — loss from operations.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exagen Inc.'s reportable segment — loss from operations?
Exagen Inc. (XGN) reported reportable segment — loss from operations of -$3.41M in Q1 2026.
How has Exagen Inc.'s reportable segment — loss from operations changed year-over-year?
Exagen Inc.'s reportable segment — loss from operations decreased by 1.5% year-over-year, from -$3.37M to -$3.41M.
What is the long-term trend for Exagen Inc.'s reportable segment — loss from operations?
Over 2 years (2023 to 2025), Exagen Inc.'s reportable segment — loss from operations has grown at a -21.5% compound annual growth rate (CAGR), from -$22.84M to -$14.07M.
What does reportable segment — loss from operations mean?
The financial result of the reportable segment's core business activities, calculated as gross profit minus total operating expenses. A negative value indicates that the segment's operational costs exceed the revenue generated from its products or services. This is a key measure of the segment's ability to achieve self-sustaining profitability.